Paper40901928
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.
Lewis CA and 2 others. PLoS Pathog, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells. Papers, record 40901928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40901928
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| HIV-1 | Major topic |
| vpr Gene Products, Human Immunodeficiency Virus | Major topic |
| Virus Latency | Major topic |
| HIV Infections | Major topic |
| Histone Deacetylases | Major topic |
| E1A-Associated p300 Protein | Major topic |
| Humans | |
| Histone Deacetylase Inhibitors | |
| Transcription, Genetic | |
| Vorinostat | |
| Hydroxamic Acids |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AI050410 | NIAID NIH HHS | United States | P30AI050410 | PubMed and NIH | NIH RePORTER |
| R01 AI143381 | NIAID NIH HHS | United States | R01AI143381 | PubMed and NIH | NIH RePORTER |
| UM1 AI164567 | NIAID NIH HHS | United States | UM1AI164567 | PubMed and NIH | NIH RePORTER |
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17620334 | The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17620334 | PubMed |
| 2 | 31042482 | Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection. | Cell Rep | 2019 | https://conductscience.org/library/papers/31042482 | PubMed |
| 3 | 7815499 | Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. | J Virol | 1995 | https://conductscience.org/library/papers/7815499 | PubMed |
| 4 | 27550312 | HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. | Sci Rep | 2016 | https://conductscience.org/library/papers/27550312 | PubMed |
| 5 | 8642659 | Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. | J Virol | 1996 | https://conductscience.org/library/papers/8642659 | PubMed |
| 6 | 33332394 | Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France. | PLoS One | 2020 | https://conductscience.org/library/papers/33332394 | PubMed |
| 7 | 31597754 | The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. | Sci Transl Med | 2019 | https://conductscience.org/library/papers/31597754 | PubMed |
| 8 | 23846220 | Altering cell death pathways as an approach to cure HIV infection. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23846220 | PubMed |
| 9 | 24336828 | A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24336828 | PubMed |
| 10 | 9360926 | Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. | Science | 1997 | https://conductscience.org/library/papers/9360926 | PubMed |
| 11 | 9371822 | Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9371822 | PubMed |
| 12 | 29100385 | Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines. | Oncotarget | 2017 | https://conductscience.org/library/papers/29100385 | PubMed |
| 13 | 25253353 | Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. | J Virol | 2014 | https://conductscience.org/library/papers/25253353 | PubMed |
| 14 | 31217357 | Clones of infected cells arise early in HIV-infected individuals. | JCI Insight | 2019 | https://conductscience.org/library/papers/31217357 | PubMed |
| 15 | 21566118 | Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21566118 | PubMed |
| 16 | 9427608 | HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. | Nat Med | 1998 | https://conductscience.org/library/papers/9427608 | PubMed |
| 17 | 38134881 | A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells. | Cell Chem Biol | 2023 | https://conductscience.org/library/papers/38134881 | PubMed |
| 18 | 31396206 | Illuminating the Role of Vpr in HIV Infection of Myeloid Cells. | Front Immunol | 2019 | https://conductscience.org/library/papers/31396206 | PubMed |
| 19 | 15832178 | To kill or be killed: how HIV exhausts the immune system. | Cell Death Differ | 2005 | https://conductscience.org/library/papers/15832178 | PubMed |
| 20 | 2136707 | Identification of HIV-1 vpr product and function. | J Acquir Immune Defic Syndr (1988) | 1990 | https://conductscience.org/library/papers/2136707 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42836275 | Manipulation of the cell cycle by HIV-1. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42836275 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| EP300 | 2033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
| HDAC9 | 9734 | PubTator's text mining | https://conductscience.org/library/genes/9734 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40901928
GET https://conductscience.org/api/papers/v1/40901928/references?page=2